Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Irish Journal of Medical Science (1971 -)
Published in: Irish Journal of Medical Science (1971 -) 2/2011

01-06-2011 | Review Article

Effects of exercise and physical activity on depression

Authors: P. C. Dinas, Y. Koutedakis, A. D. Flouris

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2011

Login to get access

Abstract

Introduction

Depression is a very prevalent mental disorder affecting 340 million people globally and is projected to become the leading cause of disability and the second leading contributor to the global burden of disease by the year 2020.

Aim

In this paper, we review the evidence published to date in order to determine whether exercise and physical activity can be used as therapeutic means for acute and chronic depression. Topics covered include the definition, classification criteria and treatment of depression, the link between β-endorphin and exercise, the efficacy of exercise and physical activity as treatments for depression, properties of exercise stimuli used in intervention programs, as well as the efficacy of exercise and physical activity for treating depression in diseased individuals.

Conclusions

The presented evidence suggests that exercise and physical activity have beneficial effects on depression symptoms that are comparable to those of antidepressant treatments.
Literature
1.
Murray CJL, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Harvard University Press, Cambridge, MA
2.
Kruijshaar ME, Hoeymans N, Spijker J, Stouthard ME, Essink-Bot ML (2005) Has the burden of depression been overestimated? Bull World Health Org 83(6):443–448PubMed
3.
Lewinsohn PM, Rohde P, Seeley JR, Fischer SA (1993) Age-cohort changes in the lifetime occurrence of depression and other mental disorders. J Abnorm Psychol 102(1):110–120PubMedCrossRef
4.
Escribá QR, Maestre MC, Amores LP, Pastor TA, Miralles ME, Escobar RF (2005) Depression prevalence in adolescents. Actas Esp Psiquiatr 33:298–302
5.
6.
Babyak M, Blumenthal JA, Herman S et al (2000) Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med 62(5):633–638PubMed
7.
Blumenthal JA, Babyak MA, Doraiswamy PM et al (2007) Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 69(7):587–596PubMedCrossRef
8.
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4th edn. American Psychiatric Association, Washington
9.
World Health Organization (1992) The ICD-10 Classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Royal College of Psychiatrists, London
10.
Powers RH, Kniesner TJ, Croghan TW (2002) Psychotherapy and pharmacotherapy in depression. J Ment Health Policy Econ 5(4):153–161PubMed
11.
Klinkman MS (1997) Competing demands in psychosocial care. A model for the identification and treatment of depressive disorders in primary care. Gen Hosp Psychiatry 19(2):98–111
12.
Gilbody S, House A, Sheldon T (2002) Improving the recognition and management of depression in primary care. Effective Health Care 7(5):1–12
13.
Williams JW, Noël PH, Cordes JA (2002) Is this patient clinically depressed? J Am Med Assoc 287(9):1160–1170CrossRef
14.
Von Korff M, Katon W, Bush T et al (1998) Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med 60(2):143–149
15.
Oxman TE, Dietrich AJ, Schulberg HC (2003) The depression care manager and mental health specialist as collaborators within primary care. Am J Geriatr Psychiatry 11(5):507–516PubMed
16.
Fichna J, Janecka A, Costentin J, Do Rego JC (2007) The endomorphin system and its evolving neurophysiological role. Pharmacol Rev 59(1):88–123PubMedCrossRef
17.
Cox RH (2002) Sport psychology: concepts and applications. McGraw-Hill Publishers, St. Louis, MO
18.
Navines R, Martin-Santos R, Gomez-Gil E, Martinez de Osaba MJ, Gasto C (2008) Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response. Prog Neuropsychopharmacol Biol Psychiatry 32(8):1804–1809PubMedCrossRef
19.
Stein DJ, van Honk J, Ipser J, Solms M, Panksepp J (2007) Opioids: from physical pain to the pain of social isolation. CNS Spectr 12 (9):669–670, 672–664
20.
Castilla-Cortazar I, Castilla A, Gurpegui M (1998) Opioid peptides and immunodysfunction in patients with major depression and anxiety disorders. J Physiol Biochem 54(4):203–215PubMed
21.
Djurovic D, Milic-Askrabic J, Majkic-Singh N (1998) Effect of fluvoxamine on the level of beta-endorphin in the sera and nervous tissue of rats. Pharmazie 53(2):143–144PubMed
22.
Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA (2009) Exercise for depression. Cochrane Database Syst Rev 3:CD004366
23.
Vaccarino AL, Olson GA, Olson RD, Kastin AJ (1999) Endogenous opiates: 1998. Peptides 20(12):1527–1574PubMedCrossRef
24.
Grisel JE, Bartels JL, Allen SA, Turgeon VL (2008) Influence of beta-endorphin on anxious behavior in mice: interaction with EtOH. Psychopharmacology (Berl) 200(1):105–115CrossRef
25.
Disham KR, O’Connor JP (2009) Lessons in exercise neurobiology: the case of endorphins. Ment Health Phys Activity (in press)
26.
Boecker H, Sprenger T, Spilker ME et al (2008) The runner’s high: opioidergic mechanisms in the human brain. Cereb Cortex 18(11):2523–2531PubMedCrossRef
27.
Wester HJ, Willoch F, Tolle TR et al (2000) 6-O-(2-[18F]Fluoroethyl)-6-O-desmethyldiprenorphine ([18F]DPN): synthesis, biologic evaluation, and comparison with [11C]DPN in humans. J Nucl Med 41(7):1279–1286PubMed
28.
Stern RA, Arruba JE, Hooper CR, Wolfner GW, Morey CE (1997) Visual analogue mood scales to measure internal mood state in aphasic patients: description and initial validity evidence. Aphasiology 11:59–71CrossRef
29.
Finley JP, Bonet JF, Waxman MB (1979) Autonomic pathways responsible for bradycardia on facial immersion. J Appl Physiol 47(6):1218–1222PubMed
30.
Goldfarb AH, Jamurtas AZ (1997) Beta-endorphin response to exercise. An update. Sports Med 24(1):8–16
31.
Lindstrom LH, Widerlov E, Gunne LM, Wahlstrom A, Terenius L (1978) Endorphins in human cerebrospinal fluid: clinical correlations to some psychotic states. Acta Psychiatr Scand 57:153–164
32.
Gross-Isseroff R, Dillon KA, Israeli M, Biegon A (1990) Regionally selective increases in μ-opioid receptor density in the brains of suicide victims. Brain Res 530:312–316
33.
Scarone S, Gambini O, Calabrese G et al (1990) Asymmetrical distribution of β-endorphin in cerebral hemispheres of suicides: preliminary data. Psychiatry Res 32:159–166PubMedCrossRef
34.
Darko DF, Risch SC, Gillin JC, Golshan S (1992) Association of β-endorphin with specific clinical symptoms of depression. Am J Psychiatry 149:1162–1167PubMed
35.
Gabilondo AM, Meana JJ, Garcia-Sevilla JA (1995) Increased density of μ-opioid receptors in the postmortem brain of suicide victims. Brain Res 682:245–250PubMedCrossRef
36.
Kline NS, Li CH, Lehman HL, Lajta A, Laski E, Cooper T (1977) β-Endorphin-induced changes in schizophrenics and depressed patients. Arch Gen Psychiatry 34:1111–1113
37.
Jamurtas ZA, Fatouros JI (2004) The effects of exercise on the levels of beta-endorphin in blood. Inq Sport Phys Educ 2(1):93–102
38.
Hung HF, Kao PF, Lin YS et al (2007) Changes of serum beta-endorphin by programmed exercise training are correlated with improvement of clinical symptoms and quality of life in female mitral valve prolapse syndrome. Cardiology 108(4):252–257PubMedCrossRef
39.
Bender T, Nagy G, Barna I, Tefner I, Kadas E, Geher P (2007) The effect of physical therapy on beta-endorphin levels. Eur J Appl Physiol 100(4):371–382PubMedCrossRef
40.
Legrand F, Heuze JP (2007) Antidepressant effects associated with different exercise conditions in participants with depression: a pilot study. J Sport Exerc Psychol 29(3):348–364PubMed
41.
Paffenbarger RS Jr, Lee IM, Leung R (1994) Physical activity and personal characteristics associated with depression and suicide in American college men. Acta Psychiatr Scand Suppl 377:16–22PubMedCrossRef
42.
Goodwin DR (2003) Association between physical activity and mental disorders among adults in the United States. Prev Med 36(6):698–703PubMedCrossRef
43.
Larun L, Nordheim LV, Ekeland E, Hagen KB, Heian F (2006) Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database Syst Rev 3:CD004691
44.
Giacobbi RP, Hausenblas AH, Frye N (2005) A naturalistic assessment of the relationship between personality, daily life events, leisure time exercise, and mood. Psychol Sport Exerc 6:67–81CrossRef
45.
Hoffman DM, Hoffman RD (2008) Exercisers achieve greater acute exercise-induced mood enhancement the no exercisers. Arch Phys Med Rehabil 89:358–363PubMedCrossRef
46.
McNeil JK, LeBlanc EM, Joyner M (1991) The effect of exercise on depressive symptoms in the moderately depressed elderly. Psychol Aging 6(3):487–488PubMedCrossRef
47.
Harris AH, Cronkite R, Moos R (2006) Physical activity, exercise coping, and depression in a 10-year cohort study of depressed patients. J Affect Disord 93(1–3):79–85PubMedCrossRef
48.
Lampinen P, Heikkinen RL, Ruoppila I (2000) Changes in intensity of physical exercise as predictors of depressive symptoms among older adults: an eight-year follow-up. Prev Med 30(5):371–380PubMedCrossRef
49.
Herman S, Blumenthal JA, Babyak M et al (2002) Exercise therapy for depression in middle-aged and older adults: predictors of early dropout and treatment failure. Health Psychol 21(6):553–563PubMedCrossRef
50.
Hoffman MB, Babyak AM, Sherwood A et al (2009) Effects of aerobic exercise on sexual functioning in depressed adults. Ment Health Phys Activity (in press)
51.
Carta MG, Hardoy MC, Pilu A et al (2008) Improving physical quality of life with group physical activity in the adjunctive treatment of major depressive disorder. Clin Pract Epidemol Ment Health 4:1CrossRef
52.
Hassmen P, Koivula N, Uutela A (2000) Physical exercise and psychological well-being: a population study in Finland. Prev Med 30(1):17–25PubMedCrossRef
53.
Beniamini Y, Rubenstein JJ, Zaichkowsky LD, Crim MC (1997) Effects of high-intensity strength training on quality-of-life parameters in cardiac rehabilitation patients. Am J Cardiol 80(7):841–846PubMedCrossRef
54.
Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO (2002) The DOSE study: a clinical trial to examine efficacy and dose response of exercise as treatment for depression. Control Clin Trials 23(5):584–603PubMedCrossRef
55.
Singh NA, Stavrinos TM, Scarbek Y, Galambos G, Liber C, Fiatarone Singh MA (2005) A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults. J Gerontol A Biol Sci Med Sci 60(6):768–776PubMed
56.
57.
Stanton JM, Arroll B (1996) The effect of moderate exercise on mood in mildly hypertensive volunteers: a randomized controlled trial. J Psychosom Res 40(6):637–642PubMedCrossRef
58.
Krawczynski M, Olszewski H (2000) Psychological well-being associated with a physical activity programme for persons over 60 years old. Psychol Sport Exerc 1(1):57–63CrossRef
59.
Smith PJ, Blumenthal JA, Babyak MA, Georgiades A, Hinderliter A, Sherwood A (2007) Effects of exercise and weight loss on depressive symptoms among men and women with hypertension. J Psychosom Res 63(5):463–469PubMedCrossRef
60.
Milani RV, Lavie CJ, Cassidy MM (1996) Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am Heart J 132(4):726–732PubMedCrossRef
61.
Fuchs R (2001) Physical activity and health. In: Smelser NJ, Baltes PB (eds) International encyclopaedia of the social and behavioural sciences, vol 17. Elsevier, New York, pp 11411–11415
62.
Berkman LF, Blumenthal J, Burg M et al (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289(23):3106–3116. doi:10.​1001/​jama.​289.​23.​3106 PubMedCrossRef
63.
Metadata
Title
Effects of exercise and physical activity on depression
Authors
P. C. Dinas
Y. Koutedakis
A. D. Flouris
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2011
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-010-0633-9

Other articles of this Issue 2/2011

Irish Journal of Medical Science (1971 -) 2/2011 Go to the issue

Original Article

Dynamic changes of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) on pulmonary injury induced by ischemia–reperfusion in rats

Case Report

Serum sickness like reaction in an 11-year-old boy

Letter to the Editor

Assessing stress in surgery: using validated tools to improve patient safety

Letter to the Editor

Tuberculosis abscess causing spinal cord compression: a rare presentation

Brief Report

Hospital-based needlestick use and injuries by Dublin interns in 2010

Case Report

Sarcoidosis presenting with severe hypocalcaemia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits